Latest News From "The Pink Sheet" DAILY

Regeneron Secures Sanofi-Aventis Antibody Funding Through 2017

Building on an existing partnership, Regeneron may receive as much as $1.3 billion from Sanofi-Aventis through 2017 with no obligation to repay.   read more

 

Pfizer's Global R&D Network: Rapid Integration Means Doing More With Less

Even as the drug maker cuts its R&D budget and staff, there are plans to maintain productivity and hit key diseases hard.   read more

 

More PBM Power Behind Pharmacogenomics: CVS Caremark Launching Program In 2010

Through a collaboration with Generation Health, CVS Caremark becomes the second of the major PBMs to publicly boost its commitment to pharmacogenomics.   read more

 

A Gem In Cephalon's Pipeline? Cinquil Offers The Promise Of A Needed Boost

Reslizumab, which is in development for eosinophilic esophagitis and severe asthma, is a drug Cephalon investors are keeping a close eye on.   read more

 

FDA Gets Strict On Liquid OTC Dosing Devices In Draft Guidance

Pediatric medicine dosing is a key driver for the guidance, which clarifies that when a dosing device fails "to bear markings consistent with the labeled dosage directions," the drug is misbranded.   read more

 

"The Pink Sheet" DAILY is the leading on-line news and analysis service for the pharmaceutical industry. For information about a subscription or to sign up for a free trial at www.thepinksheetdaily.com